Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL209P is a human pseudogene closely related to the canonical 7SL RNA gene. The canonical 7SL RNA is integral to the Signal Recognition Particle (SRP), a ribonucleoprotein involved in cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[1][5]. RN7SL209P, as a pseudogene, is a noncoding RNA sequence that has lost its original function and does not encode a functional RNA or protein product. 7SL RNA pseudogenes typically arise by reverse transcription of 7SL RNA followed by insertion into genomic DNA, often showing truncations at either the 5’ or 3’ ends[3][8]. While some pseudogenes in the human genome may play regulatory roles—such as serving as competitive endogenous RNAs (ceRNAs), miRNA sponges, or having tissue-specific expression—there is no direct evidence that RN7SL209P shows such activity[2][4][6][9]. The majority of 7SL-like sequences in human DNA are pseudogenes, and only a small number actually encode the functional SRP RNA[8][9]. RN7SL209P is not considered a therapeutic target, receptor, or enzyme, and is not associated with human disease or pharmacological intervention.
Not applicable; not a canonical drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 209, pseudogene (RN7SL209P).